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Growth plate chondrocytes undergo a tightly regulated process of differentiation, allowing for the longitudinal growth of bones. Although it is
known that parathyroid hormone related protein (PTHrP) and Indian hedgehog regulate the differentiation of growth plate chondrocytes, how
these pathways interact to regulate chondrocyte development is not fully elucidated. We examined how the interaction between PTHrP and the
hedgehog activated transcription factors, Gli2 and Gli3, regulates growth plate chondrocyte differentiation and proliferation. Analysis of fetal
limbs showed that Gli2 is a negative regulator and Gli3 a positive regulator of type X collagen expression. Limb explant cultures showed that
PTHrP treatment inhibited type X collagen expression and increased chondrocyte proliferation. This effect was substantially enhanced in Gli2−/−
limbs, was blocked in Gli3−/− limbs, and was only partially inhibited by hedgehog ligand blockade. PTHrP negatively regulated Gli mediated
transcription in cell cultures, and regulated the level of the repressor form of Gli3 in a PKA dependent manner. These results show that PTHrP
regulates growth plate chondrocyte proliferation and differentiation in part through the activity of Gli3, suggesting a crucial role for Gli3 in growth
plate chondrocyte development.
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The long bones of the body form by enchondral ossification,
a process in which a cartilage is replaced by osseous tissue.
During embryonic development, mesenchymal progenitor cells
condense to form a cartilaginous template of the long bones.
Blood vessels and osteoblasts appear in the middle of the
cartilage to form a primary center of ossification. The
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surface, and growth plate chondrocytes that are located towards
the center of the bone. A secondary ossification center forms
between these two populations of chondrocytes. The growth
plate is responsible for the longitudinal growth of the bone, and
growth plate chondrocytes undergo an orderly process of
differentiation, in which resting cells proliferate, hypertrophy,
and undergo terminal differentiation, during which they lay the
scaffolding for new bone formation (Linsenmayer et al., 1988;
Olsen et al., 2000).
A variety of signaling pathways are crucial for normal
growth plate chondrocyte differentiation, including parathyroid
hormone related protein (PTHrP) and Indian hedgehog (Ihh).
These two signaling pathways act in a feedback loop regulating
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tion acting to delay terminal differentiation (Karp et al., 2000;
Kobayashi et al., 2002; Lanske et al., 1996; Minina et al., 2001).
PTHrP signals though PTHR1, which is a 7 transmembrane
type II G-protein coupled receptor. Ligand binding activates
several secondary messenger pathway including PKA, IP3, and
PKC (Gensure et al., 2005). Studies in-vitro suggest that PKA
mediates much of the effect of PTHrP on chondrocyte
maturation (Zhang et al., 2003). The importance of PTHR1 in
growth plate function is highlighted by the demonstration that
mutations in this receptor cause metaphyseal chondrodyspla-
sias, conditions that are characterized by abnormal growth plate
chondrocyte maturation (Schipani et al., 1996).
Hedgehog (Hh) ligands bind to the Patched (Ptch1) receptor.
This binding inactivates smoothened inhibition, which results in
hedgehog mediated transcriptional factor(s) becoming active in
the nucleus. In Drosophila, hedgehog signaling activates the
transcription factor cubitus interruptus (Ci). In the absence of
hedgehog binding, Ci is tethered to microtubules where it is
cleaved, resulting in a portion that acts as a transcriptional
repressor. With hedgehog receptor activation, unprocessed Ci
functions as a transcriptional activator. In mammals, there are
three transcription factors: Gli1, Gli2 and Gli3. The regulation
of the Gli transcription factors by hedgehog is more complex.
Gli1 has a transcriptional activating domain, while Gli2 and
Gli3 contain both transcriptional activating and repressing
domains. Although this raises the possibility that Gli1 is a
constitutively active, mice deficient in Gli1 show no readily
apparent phenotype, suggesting that this factor is not required
for normal physiologic function. Gli2 and Gli3 transcriptional
activation are regulated by hedgehog signaling, however, the
control of transcriptional activation does not appear to be a
simple as for Ci. Hedgehog signaling inhibits the formation of
the Gli3 repressor form but apparently not that of Gli2. This,
and findings from mice deficient in Gli2 or Gli3, led to the
notion that Gli2 has acts primarily to activate hedgehog
mediated transcription, while Gli3 can act as either a repressor
or activator depending on the cell specific context (Cohen,
2003; Dominguez et al., 1996; Matise and Joyner, 1999; Mullor
et al., 2002; Nieuwenhuis and Hui, 2005). Interestingly, Gli
mediated transcription results in elevation of Gli1 and Ptch1
transcripts, potentially acting as a transcriptional feedback loop
in hedgehog signaling activation (Johnson et al., 1995; Marigo
and Tabin, 1996; Schipani et al., 1997). Besides their regulation
by hedgehog ligand signaling, the Gli proteins may also be
regulated by other signaling pathways. For example, Gli2 and
Gli3, are implicated in fibroblast growth factor signaling in
mesodermal development in the frog (Brewster et al., 2000).
This raises the possibility that Gli transcription factors act as
integrators of multiple signaling pathways.
Given the important role of hedgehog signaling in bone
development, it is not surprising that mice deficient in Gli2
develop substantially abnormal bones. Gli2−/− mice are not
viable, but have been investigated during embryonic develop-
ment. They show an increase in the length of cartilaginous
growth plates, increased numbers of hypertrophic growth plate
chondrocyte cells, and reduced bone formation. Theses changeswere accompanied by a decreased expression of Ptch1 and
PTHrP, consistent with decreased hedgehog transcriptional
activation (Miao et al., 2004). Genetic studies in mice show that
Gli3 acts as an important transcription factor regulating the
effect of Ihh on growth plate function. Deficiency of Gli3 will
rescue the phenotype imparted by Ihh deficiency, giving support
to the notion that Gli3 acts as a negative regulator of Hh
mediated signaling in growth plate chondrocytes (Koziel et al.,
2005).
Phosphorylation is required in the processing and transcrip-
tional activation of Ci, and PKA is one of a variety of factors
which plays a role in this phosphorylation. PKA activation will
also inhibit Gli mediated transcription (Epstein et al., 1996;
Riobo et al., 2006). As such, PKA regulation by PTHrP might
directly influence Gli mediated transcription, even in the
absence of hedgehog ligand. In this study, we examine how
PTHrP regulates the Gli transcriptional activation and the effect
on terminal differentiation in growth plate chondrocytes.
Methods
Mice
The extra toes mutant mouse, which harbors heterozygous inactivating
mutation in Gli3 (Hui and Joyner, 1993), was used to generate fetal Gli3−/−
mice. Homozygous mice are not viable, but will develop past embryonic day
18.5. To investigate the role of Gli2 deficiency in growth plate function, a mouse
harboring a targeted deletion in Gli2 was utilized (Mo et al., 1997). Like the
extra toes mutant mouse, homozygous Gli2 deficient mice are not viable, but
will develop past embryonic day 18.5. Embryonic mice were obtained from
timed pregnancies and the genotype of the various mice determined as
previously reported (Hui and Joyner, 1993; Mo et al., 1997). In all cases,
littermate wild-type mice were used as controls.
Cell lines and Gli transcriptional activation analysis
Mesenchymal progenitor cell lines, C2C12 and C3H10T1/2, were used to
analyze Gli transcriptional activation, as these cells exhibit some properties of
growth plate chondrocytes (Denker et al., 1995; Gu et al., 2004). These cells
lines expressed PTHR1 at only very low levels, and for this reason, we generated
cell lines stably transfected with a Flag-tagged PTHR1. Epitope mapping studies
have previously shown minimal alterations in PTHR1 signaling due to the
addition of a Flag tag (Xie and Abou-Samra, 1998). We used PCR to tag a
PTHR1-pcDNA1/AMP construct (obtained from Dr. H. Juppner, Massachusetts
General Hospital, Boston) with a Flag epitope. In-vitro transcription translation
was used to verify that this construct would produce a protein of predicted size.
Fugene-6 (Roche) was used for transfections, and antibiotic suppression (G418,
Multicell), was used to select cells that had been successfully transected. To
verify successful transfection of PTHR1, immunofluorescent staining to the Flag
epitope was utilized. Cells were grown on coverslips, rinse twice with sterile
PBS, fixed in 4% paraformaldehyde, followed methanol. The sections were
stained using an anti-Flag mouse monoclonal M2 from Sigma followed by
secondary fluorescent dye-conjugated antibody (DAKO). To determine if
PTHrP could regulate Gli mediated signaling with constitutive activation of
hedgehog signaling, we utilized mouse embryonic fibroblatsts derived from
Ptch1−/− mice (Goodrich et al., 1997; Bailey et al., 2002).
The cell cultures were examined for Gli transcriptional activity by transient
transfection with a Gli-reporter construct, in which the Gli promoter consensus
sequence 5′-GACCACCCA-3′ regulates expression of luciferase protein
(Sasaki et al., 1997), and using real time PCR for the hedgehog target gene,
Ptch1, and Gapdh as a control. The Gli reporter construct was transfected
along with a β-galactosidase expression construct as a control for transfection
efficiency. In order to determine the effect of hedgehog and PTHrP signaling on
Gli activation, the cell cultures were examined under a variety of treatment
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ide (Alexis Biochemicals), at 20 μM; the hedgehog ligand, Shh-N at 10 μg/ml
(Ontogeny Inc., Cambridge, Massachusetts, USA); 10−7 M PTHrP (Bachem,
King of Prussia, Pennsylvania, USA); the hedgehog inhibitor cyclopamine at
10−4 M (Biomol Research Laboratories, Inc., Plymouth Meeting PA); the
cyclopamine analogue lacking hedgehog blocking activity, tomatidine, as an
additional control at 10−4 M (Sigma, St. Louis, Missouri, USA); or 10 μg/ml
neutralizing 5E1 anti-hedgehog monoclonal antibody (Hybridoma Bank,
University of Iowa).
β-Galactosidase activity and luciferase activity were measured as previously
reported (Meng et al., 2001), and Gli transcriptional activity was represented by
luciferase activity normalized for β-galactosidase. To assay for PKA activity and
determine effective inhibition at the H-89 dosages used in our studies, 5 μl of
cell culture lysate was assayed using a commercially available PKA activity
assay kit (Promega Biosciences, San Luis Obispo, CA). Each experiment was
performed at least in triplicate. The results obtained using cyclopamine were
verified using the neutralizing antibody.
Explant cultures
Embryonic hindlimb organ cultures from 16.5 dpc limbs were established as
previously described (Lanske et al., 1996; Minina et al., 2001). Limbs were
placed on a Nucleopore filter inside a well of a 24-well tissue culture plate, with
the limb at the liquid/air interface. The limb explants were then cultured for
4 days at 37 °C in a 5% CO2 incubator, initially in media containing 5% fetal calf
serum. After 1 day in culture, the media was changed to 0.1% FBS, with various
agents added to the media. 10−7 M PTHrP (Bachem, King of Prussia,
Pennsylvania, USA) was added to activate PTHrP signaling. To block hedgehog
ligand mediated singling, cyclopamine was utilized at 10−4 M concentration. As
a control for cyclopamine, an analogue which lacks hedgehog signaling
properties, tomatidine (Sigma, St. Louis, Missouri, USA) was utilized (Tiet et
al., 2006). Each explant experiment was undertaken six times using limbs from
six different fetal mice and littermate controls. As an additional control for
blocking hedgehog ligand, 10 μg/ml of neutralizing 5E1 anti-SHH monoclonal
antibody (Hybridoma Bank, University of Iowa) was utilized in a single explant
culture to verify the results obtained using cyclopamine.
Proliferation was measured using Bromdeoxyuridine (BrdU) incorporation.
Explant specimens were incubated with BrdU for the final 12 h of culture. An
anti-BrdU antibody was used as previously reported to detect cells which had
taken up BrdU during this 12 h period (Alman et al., 1996). The proportion of
BrdU positive cells was calculated in the proliferative zone of the growth plate
by counting the number of positive and negative cells over 10 high powered
fields. Apoptosis was measured using a TUNEL assay as previously reported
(Tiet et al., 2006). Positively stained cells were analyzed in a similar manner as
for BrdU incorporation.
Immunohistochemistry
Fetal limbs at embryonic day 16.5 or 18.5, or explant cultures were
examined for expression of Gli2, Gli3, and type X collagen by immunohis-
tochemistry using previously reported techniques and antibodies (Hu et al.,
2006; Linsenmayer et al., 1988; Saika et al., 2004; Tiet et al., 2006; Wang et al.,
2000). Type X collagen is an exclusive marker of growth plate chondrocyte
terminal differentiation, and was used as a marker for hypertrophic growth plate
chondrocytes. Since growth plate morphology varies with the anatomic location,
we used the proximal tibial growth plate for all analyses.
Western analysis for Gli3 processing
Nuclear extracts were prepared from cell cultures using centrifugation as
previously reported (Meng et al., 2001). A Gli3 antibody (H-280 antibody from
Santa Cruz) that recognizes both the full length and truncated form of the protein
was used in Western analysis to determine expression level of the Gli3 repressor
(Hu et al., 2006; Saika et al., 2004; Wang et al., 2000). The membranes for the
Western were stripped and probed using an antibody to actin as a loading
control. Densitometry was used to compare protein levels between the full
length activator and truncated repressor forms of Gli3.Statistical analysis
In the explant studies, at least six limbs from different mice of a given
genotype were examined, along with six limbs from wild-type littermates as
controls. For cell culture experiments, each was performed at least in
triplicate. Sections for immunohistochemistry, TUNEL staining, and BrdU
importation studies were observed under light microscopy. The percent BrdU
incorporation, percent TUNEL stained cells, or the height of the zone of the
growth plate staining for type X collagen was measured by a blinded observer.
For all of the data, the mean, 95% confidence intervals, and standard
deviations were calculated for each condition. These were compared using the
Student t-test.Results
Expression of Gli proteins in the growth plate
Fetal limbs from wild-type, Gli2−/−, and Gli3−/− mice were
analyzed for expression of the Gli2 and Gli3 transcription
factors using immunohistochemistry. The proximal tibial
growth plates from E16.5 limbs were examined. In wild-type
mice, there was diffuse expression of Gli2 throughout the
growth plate, although there was slightly less expression in
terminally differentiating, hypertrophic, growth plate chondro-
cytes (Fig. 1A). In contrast, Gli3 was expressed at substantially
lower levels in the hypertrophic zone (Fig. 1D). Gli2 expression
was lacking in limbs from Gli2 null mice, and expression of
Gli3 was lacking in mice null for Gli3 (Figs. 1C and F).
Although there was not an obvious change in the distribution of
Gli2 in Gli3−/− mice, in Gli2−/− mice, there was an extended
range of expression of Gli3, extending into the hypertrophic
zone (Figs. 1B and E). This expression pattern of Gli3 is similar
to that reported in earlier stage embryonic limbs using in-situ
hybridization (Koziel et al., 2005), with the transcription factor
primarily expressed by cells which have not yet entered the
hypertrophic zone.
Type X collagen expression in growth plate chondrocytes is
regulated by the Gli genes
To determine what role Gli genes might play in the
regulation of growth plate chondrocyte differentiation, the
region of expression of type X collagen, a marker of
hypertrophic growth plate chondrocytes, was compared
between mutant and wild type fetal mice at 16.5 and
18.5 dpc. In 16.5 dpc mice there was a decreased height to
the region of type X collagen expression in the Gli3−/− mice
compared to wild-type littermates, and an increased height to
the region of type X collagen expression in Gli2−/− mice
compared to wild-type littermates (Fig. 2). These differences
were, however, much more dramatic in the 18.5 dpc limbs
compared to 16.5 dpc limbs. This pattern suggests a positive
role for Gli3 and a negative role for Gli2 in the regulation of the
height size of the zone of type X collagen expression in the
growth plate. The more dramatic difference in the slightly older
fetal limbs illustrates that the regulation of hypertrophic
chondrocytes by Gli genes in the growth plate depends on the
stage of development.
Fig. 1. Expression of Gli proteins in the growth plate. Immunohistochemistry for Gli2 (panels A, B and C), and Gli3 (panels D, E, and F). The proximal tibial growth
plate from E16.5 wild-type, Gli3−/−, and Gli2−/− limbs were examined. In wild-type mice (panel A), there was diffuse expression of Gli2 throughout the growth
plate, although slightly less expression in terminally differentiating, hypertrophic growth plate chondrocytes. In Gli3−/−mice, there was a slightly elevated expression
level in chondrocytes in the zone of terminal differentiation (panel B). There was no expression in growth plates from Gli2−/−mice (panel C). In wild-type mice, Gli3
was expressed at lower levels in the zone of terminal differentiation (panel D). Gli2−/−mice showed an extended range of expression of Gli3, extending into the zone
of terminal differentiation (panel E). Gli3−/− mice lacked expression of Gli3 in their growth plates (panel F).
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cell lines
Cell cultures derived from mesenchymal progenitors were
used to investigate the regulation of Gli mediated transcrip-
tion by PTHrP. Because these cell lines did not express
PTHR1, we generated cells transfected with a construct
driving expression of the receptor. The ability of the construct
to produce PTHR1 protein was confirmed using an in-vitro
transcription translation assay (Fig. 3A), and the expression in
cells was determined using immunohistochemistry to the Flag
tag (Fig. 3B). The regulation of PTHR1 mediated signaling
by PTHrP was assayed by measuring PKA activity. The
ability to regulate this activity was abolished with the addition
of PKA-specific inhibitor, H-89 (Figs. 3C and D). In both cell
lines, there was little regulation of PKA activity in the
absence of transfection with PTHR1, and treatment with H-89
brought PKA levels to baseline. PKA activity was also
increased in the Ptch1−/− mouse embryonic fibroblasts with
PTHrP treatment, showing that these cells are responsive to
PTHrP (Fig. 3E).
To determine the regulation of PTHrP on Gli mediated
transcription, the cells were assayed for activity of a Gli reporter
construct and expression level of the hedgehog target gene,Ptch1. Activity was compared between stimulation with
hedgehog ligand, with the hedgehog signaling inhibitor
cyclopamine, with PTHrP, and the PKA inhibitor H-89. Dose
response studies were undertaken to ensure that these agents
were able to completely block the effect of hedgehog ligand
stimulation. As expected, hedgehog ligand stimulation
increased Gli transcriptional activation. PTHrP, on the other
hand, decreased Gli mediated transcription to roughly 50% of
control levels. Intriguingly, PTHrP was able to cause this
decrease even in the presence of hedgehog ligand activation or
hedgehog signaling blockade by cyclopamine (Figs. 4A and B).
The data from the use of the neutralizing antibody was identical
to that with use of cyclopamine (data not shown). These
differences were significant with a p<0.05. Real time RT-PCR
data confirmed that the level of expression of Ptch1 correlated
with Gli transcriptional activation level (data not shown). The
effect of PTHrP stimulation on Gli transcriptional activation
was inhibited by treatment with the PKA inhibitor. This effect
was noted not only in the C2C12 and C3H10T1/2 cell lines, but
also in the Ptch1−/− mouse embryonic fibroblasts (Fig. 4C).
Since the Ptch1−/− cells exhibit constitutive hedgehog signal-
ing activation, there was a high baseline to the level of Gli
transcriptional activation, but PTHrP treatment was still able to
decrease the level of Gli transcriptional activation. These
Fig. 2. Expression of type X collagen in the growth plate of Gli mutant mice. Immunohistochemistry using an antibody to type X collagen was utilized to compare the
height of the zone of hypertrophic growth plate chondrocytes between Gli2−/−, Gli3−/−, wild type littermate fetal mice at 16.5 and 18.5 dpc. There was a decreased
height to the region of type X collagen expression in the Gli3−/− mice compared to wild-type littermates, and an increased height to the region of type X collagen
expression in Gli2−/− mice compared to wild-type littermates. The bar in the figures is 1 mm long. The means and 95 confidence intervals for the height of the zone
staining for type X collagen (cm) are shown in graphic form. A line with an asterisk over it indicates a statistically significantly difference (p<0.05) in the height of the
type X collagen zone compared to the wild-type limbs.
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regulation of Gli mediated transcription that is at least partially
independent of the regulation of hedgehog ligand, and
dependent on PKA.
PTHrP stimulation regulates type X collagen expression in
growth plate chondrocytes in a Gli dependent manner
To determine how PTHrP regulates growth plate chondro-
cyte differentiation in the various Gli deficient limbs, we
established fetal limb organ cultures, and compared the effect
of PTHrP and hedgehog blockade to treatment with carrier or
controls (tomatidine, a cyclopamine analogue that lacks the
ability to block hedgehog ligand mediated signaling). As
expected, in wild type mice PTHrP treatment resulted in a
decline in the size of the area of type X collagen staining (Figs.
5A through C). Surprisingly, in Gli2−/− mice there was a
substantially exaggerated effect of PTHrP on type X collagenstaining, while in Gli3−/− mice the effect was substantially
blunted (Fig. 5I though L and Q through T). These results
suggest that Gli3 and Gli2 act opposite each other in the
regulation of growth plate chondrocyte differentiation and the
lack of a change in the size of the zone of terminal
differentiation in Gli3−/− limbs implicates Gli3 as the
predominant transcription factor regulating the effect of
PTHrP on type X collagen expression.
In the presence of hedgehog blockade with cyclopamine,
PTHrP was still able to exert an effect on the size of the zone
of cells expressing type X collagen. However, the effect of
PTHrP was blunted compared to tomatidine treated controls
(Fig. 5E through H and M through P). In Gli3−/− mice, there
was little effect of PTHrP stimulation on type X collagen
staining in the presence of hedgehog blockade (Fig. 5U
through X). Taken together, these results suggest that Gli3
plays an important role in how PTHrP regulates the zone of
type X collagen expression, and that PTHrP can regulate
Fig. 3. PTHrP regulation of Gli mediated transcription. An in-vitro transcription translation assay (panel A) showed that the Flag tagged construct produced PTHR1
protein of predicted size. Immunofluorescence using an anti-flag antibody showed that the cells were efficiently transfected with the construct, a representative
photomicrograph from C3H10T1/2 cells is shown (panel B). PTHrP regulated PKA activity, which was blocked by the PKA-specific inhibitor, H-89. Means and 95%
confidence intervals for PKA activity under different conditions are given in panel C, D, and E for the C2C12, C3H10T1/2 cell lines, and Ptch1−/− cells respectively.
PTHrP regulates PKA activity in C2C12 and C3H10T1/2 cell lines expressing PTHR1 (pcDNA is cells transfected with an empty vector as a control), as well as in the
cells from Ptch1−/− mice.
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independent manner.
PTHrP regulates growth plate chondrocyte proliferation in a
Gli3 dependent manner
Since PTHrP and hedgehog signaling also regulate growth
plate chondrocyte proliferation, we examined limb explant
cultures to determine how PTHrP and the Gli genes interact in
the regulation of growth plate chondrocyte proliferation. We
investigated the bromodeoxyuridine (BrdU) incorporation rate
in limb explants treated with PTHrP or carrier. There was a
higher rate of proliferation in Gli3−/− mice compared to
Gli2−/− mice, suggesting that the level of hedgehog transcrip-
tional activation regulates growth plate chondrocyte prolifera-
tion (Figs. 6A, C, and E). We found an increased BrdU
incorporation rate with PTHrP treatment in wild-type limbs. In
contrast, the increase in proliferation rate was substantially
greater in Gli2−/− mice, while we found little change in
Gli3−/−mice (Figs. 6B, D, and F). Taken together with our data
on the interaction of PTHrP and Gli in regulating the size of the
zone of type X collagen expression in the growth plate, this
suggests a tight coordination between growth plate chondrocyte
proliferation and differentiation, regulated at least in part by Gli
transcriptional activation.In contrast to our data on proliferation and type X collagen
staining, we saw only small numbers of TUNEL positive cells
in the explants and there was no change in the proportion of
positively stained cells under any of the treatment conditions.
PTHrP stimulation regulates Gli3 processing
To determine how PTHrP regulates Gli3 activity in the
absence of hedgehog blockade, we examined our cell cultures
for the level of expression of Gli3 in its full length activator, and
truncated repressor form. Since our data suggests that PTHrP
regulates Gli transcriptional activity and growth plate chon-
drocytes terminal differentiation even in the presence of
hedgehog receptor inhibition, we examined the ability of
PTHrP to regulate Gli3 processing independent of hedgehog
ligand. Using Western analysis, we determined the relative
amount of Gli3 that is present in the repressor form in nuclear
fractions compared to the full length activator form. We found
that PTHrP treatment increased the amount of Gli3 repressor
form present in the C3HT101/2, Ptch1−/−, and C2C12 cell
lines (Fig. 7). In the presence of hedgehog inhibition, PTHrP
treatment was still able to regulate the amount of GLI3 present
as the inhibitory form. Hedgehog treatment substantially
reduced the amount of Gli3 repressor present, and PKA
blockade, using H-89, abolished the ability of PTHrP to
Fig. 4. PTHrP regulation of Gli transcriptional activity. Data from the C2C12 cell are shown in panel A, and from the C3H10T1/2 cell line in panel B. Gli
transcriptional activity in the presence of cyclopamine (panels B and C). Means for relative Gli activity and 95% confidence intervals for different cell culture
conditions are shown. PTHrP has an effect of Gli activity even in the presence of hedgehog signaling blockade or hedgehog ligand stimulation. Data in panel C from
the C2C12 cell line, the C3H10T1/2 cell line, and from Ptch1−/− cells shows that the downregulation of Gli transcriptional activation, which is present in all three cell
lines, is dependent on PKA.
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ligand independent process by which PTHrP can process Gli3
that is dependent on PKA regulation.
Discussion
PTHrP and Hedgehog signaling play crucial roles regulating
growth plate chondrocyte differentiation. Genetic and biochem-
ical studies show that these pathways regulate each other, but
the mechanism by which this regulation occurs has not been
completely elucidated. In our study, we examined interactions
between PTHrP and the hedgehog mediated transcription
factors Gli2 and Gli3. PTHrP is known to inhibit growth plate
chondrocyte terminal differentiation and regulate chondrocyte
proliferation (Harrington et al., 2004; Kobayashi et al., 2002).
We found that the ability of PTHrP to regulate growth plate
chondrocyte proliferation and differentiation depends on the Gli
genes present. Intriguingly, this regulation was only partially
dependent on hedgehog ligand activity, identifying a hedgehog
ligand independent mechanism by which PTHrP directly
regulates Gli activity.
Our data supports a crucial role for the Gli transcription
factors in the regulation of chondrocyte differentiation and
proliferation. This is not unexpected, given the role of Ihh in the
regulation of growth plate chondrocytes, and previous data on
the Gli genes in skeletal development (Miao et al., 2004; Hiltonet al., 2005; Koziel et al., 2005; Mo et al., 1997). Gli2 and Gli3
often act as positive and negative regulators of hedgehog
mediated signaling respectively (Mo et al., 1997; Motoyama et
al., 2003). Since mice deficient in Gli2 have a larger zone of
expression of type X collagen, and mice deficient in Gli3 have a
smaller zone of expression of type X collagen, these transcrip-
tion factors act in opposing ways to regulate growth plate
chondrocyte differentiation. In addition, organ explant cultures
from Gli2−/− mice have a lower proliferation rate than organ
cultures from wild type or Gli3−/− mice. Thus Gli2 acts to
inhibit differentiation and promote proliferation, while Gli3 acts
in the opposite manner.
The expression pattern of the Gli2 and Gli3 suggest that they
play a role in the chondrocytes prior to entering the hypertrophic
zone. This finding, and the negative relationship between the
proliferation rate and the size of the zone of terminal
differentiation, provides further evidence that proliferation and
differentiation are tightly coupled in the growth plate.
Furthermore, the effect of Gli2 and Gli3 deficiency on terminal
differentiation is dependent on the age of development, with a
more predominant effect in 18.5 dpc limbs than in 16.5 dpc
limbs. This finding is consistent with the notion that growth
plate chondrocytes are regulated by the Gli genes in both a
temporal and special manner.
The exaggerated effect of PTHrP treatment on terminal
differentiation and proliferation in Gli2−/− mice, in concert
Fig. 5. PTHrP regulation of type X collagen in growth plate chondrocytes. Fetal limb organ cultures from Gi2−/−, Gli3−/−, or wild type littermates were treated with
cyclopamine, tomatidine (cyclopamine analogue that lacks the ability to block hedgehog ligand mediated signaling), PTHrP, or carrier. The brown color is stained for
type X collagen. The whole tibia is shown in panels A, C, E, G, I, K, M, O, Q, S, U, and W, while higher magnification views of the proximal tibial growth plate is
shown in panels B, D, F, H, J, L, N, P, R, T, W, and X. The bar in these figures is 0.01 mm long. PTHrP treatment resulted in a decline in the size of the zone of type X
collagen expression in wild-type mice (panels A through D). Gli2−/− showed a substantially exaggerated effect of PTHrP on type X collagen expression, while in
Gli3−/−mice the effect was substantially blunted (panels I though L and Q though T). In the presence of hedgehog blockade with cyclopamine, PTHrP was still able to
exert an effect on the size of the zone of cells expressing type X collagen. However, the effect of PTHrP was blunted compared to tomatidine treated controls (panels E
though H and M though P). In Gli3−/− mice, there was no effect of PTHrP stimulation on terminal differentiation in the presence of hedgehog blockade (panels U
though X). The mean and 95% confidence intervals for the height of the zone of type X collagen staining from the proximal tibial growth plate is shown in the graph in
panel Y (length in mm). A line with an asterisk above it indicates a statistically significant difference (p<0/05). The full tibia and proximal tibial growth plate
photomicrographs are taken from different explant cultures.
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Fig. 6. PTHrP regulates growth plate chondrocyte proliferation in a Gli3
dependent manner. Bromodeoxyuridine (BrdU) incorporation in Gli3−/−,
Gli2−/−, and wild-type littermate explant limb cultures. There were a higher
proportion of cells incorporating BrdU in Gli3−/− mice compared to Gli2−/−
mice (panels A, C, and E). The ability of PTHrP to increase the BrdU
incorporation rate was enhanced inGli2−/− limbs (panels B and D), while it was
substantially blunted in Gli3−/− limbs (panel F). Graphs show the mean and
95% confidence intervals for the percent of cells in the proliferative zone of the
growth plate that stained for BrdU. A line with an asterisk above it indicates a
statistically significant difference (p<0/05).
36 E. Mau et al. / Developmental Biology 305 (2007) 28–39with the blunted effect in Gli3−/− mice suggests that the
PTHrP mediated effect on differentiation is regulated by Gli-
3. Gli3 can be act as either a repressor or activator of
transcription, while Gli2 seems to function primarily as a
transcriptional activator. PTHrP treatment alters the amountof Gli3 repressor in the nucleus through ligand dependent
and independent processes. By decreasing the expression of
hedgehog ligands, the cells decrease their Gli mediated
transcriptional activation through regulation of hedgehog's
membrane receptor. However, we also found a ligand
independent regulation that is mediated by PKA. The
increase in PKA level associated with PTHrP signaling
also plays a role directly regulating the processing of Gli3.
As such, the PTHrP regulation of differentiation through Gli
mediated transcription likely functions through regulation of
Gli3, with its cleavage changing it from a transcriptional
activator to a repressor.
The interpretation of the results of any study examining
genetically modified mice can be confounded by the genetic
change altering the population of cells present in the tissues
examined. While the possibility that the changes we observed
in our explant experiments is due to a shift in cell populations
can not be completely ruled out, the complimentary findings
from the various mutant mice makes this possibility less
likely.
Besides functioning in growth plate development, PTHrP
plays an important role in other physiologic and pathologic
processes. It is possible that it could affect such processes by
modulating hedgehog mediated transcription, in either the
presence or absence of hedgehog ligand. For instance, there
is improved survival in patients with breast cancers
expressing PTHrP (Henderson et al., 2001, 2006). Further-
more, breast cancers exhibit evidence of activated hedgehog
signaling, and hedgehog signaling blockade inhibits growth
in breast cancer cell lines (Kubo et al., 2004). It is possible
that PTHrP imparts its effects on breast cancer by regulating
Hedgehog signaling in a similar manner as it does in growth
plate chondrocytes.
Several studies found that PTHrP and Ihh have differing
effects on different chondrocyte populations (Deckelbaum et
al., 2002; Iwasaki et al., 1997; Kindblom et al., 2002;
Kobayashi et al., 2002, 2005; Lanske et al., 1996; Yoshida et
al., 2001). Our data showing that PTHrP exerts its regulation of
differentiation through Gli3, and that Gli3 expression is limited
to only select growth plate chondrocytes, explains the restriction
of the effect of PTHrP to only select populations of growth plate
chondrocytes. In addition, the mild compensatory increase in
the region of growth plate chondrocytes expressing Gli3 in mice
deficient in Gli2, may partially explain the exaggerated
phenotypic effect observed from PTHrP treatment in the Gli2
mutant mice.
We previously found that transgenic mice over-expressing
Gli2 in the growth plate develop rests of chondrocytes in the
metaphysic that fail to undergo terminal differentiation (Tiet et
al., 2006). These metaphyseal cartilage rests are similar in
appearance to a condition in humans in which benign cartilage
tumours are found in the metaphysis, called enchondroma-
tosis. The tumours that occur in this condition are associated
with hedgehog signaling activation (Tiet et al., 2006). Our
current findings are consistent with our supposition that Gli2
activation in the transgenic mice inhibits terminal and
promotes chondrocyte proliferation. Taken together with our
Fig. 7. PTHrP stimulation regulates Gli3 processing independent of hedgehog signaling. Western analysis from C3H10T1/2 and Ptch−/− cells subjected to various
conditions. The repressor form of Gli3 is downregulated with hedgehog ligand treatment, and upregulated with PTHrP treatment. Even in the presence of cyclopamine,
PTHrP can further upregulate the amount of Gli3 repressor form present in the nucleus in C3H10T1/2 cells. In Ptch1−/− cells, PTHrP can regulate the suppressor form
of Gli3 even in the presence of constitutive hedgehog signaling. The regulation of the repressor form of Gli3 by PTHrP is dependent on PKA. The bottom panel shows
the means and 95% confidence intervals of the ratio of the densities between the truncated repressor form and full length activator form on Gli3 from the various cell
culture experiments. A higher value indicates an increased proportion of the repressor form present. An immunoblot from Gl3+/+ and Gli3−/− embryos shows the
specificity of the Gli3 antibody.
Fig. 8. A model for the mechanism by which PTHrP regulates growth plate
chondrocytes through the Gli transcription factors. PTHrP acts to regulate the
progression of growth plate chondrocytes from a proliferative to the
hypertrophic zones by regulating the activity of the Gli transcription factors.
It is able to do this by both regulating hedgehog ligand activity and by regulating
the processing of Gli3 in a hedgehog ligand independent, PKA dependent,
manner.
37E. Mau et al. / Developmental Biology 305 (2007) 28–39current data, this shows that a crucial balance between Gli
transcriptional activation and repression must exist for normal
physiologic growth plate function. Tipping the balance
towards Gli activation, increases proliferation, and inhibits
terminal differentiation, predisposing to pathologic conditions,
such as enchondromatosis.
While we found that PTHrP regulates Gli transcriptional
activity, genetic studies found that PTHrP expression is
dependent on hedgehog activity. As such, PTHrP and hedgehog
transcriptional activity exist in a complex feedback loop in
growth plate chondrocytes. We propose a model in which
PTHrP inhibits the progression of growth plate chondrocyte
differentiation from their proliferative state to the zone of
hypertrophy and terminal differentiation, mediated by Gli3
transcriptional activity (Fig. 8). PTHrP regulates the activity of
Gli3 through both a hedgehog ligand dependent, and a
hedgehog ligand independent, PKA dependent pathway. Gli3
is expressed primarily in growth plate chondrocytes which have
not yet undergone terminal differentiation, and as such, the
PTHrP regulation of Gli3 functions primarily on chondrocytes
that have not yet entered their terminally differentiated state.
The ability of PTHrP and its regulation of Gli transcriptional
activity to regulate the height of the zone of growth plate
chondrocytes producing type X collagen, a marker of terminal
differentiation, despite a lack of Gli3 expression in these
chondrocytes supports the concept that growth plate chondro-cyte proliferation and differentiation are inversely related. As
such, activation of Gli mediated signaling increases prolifera-
tion and inhibits terminal differentiation, and PTHrP acts
through its ability to regulate Gli3 to control the progression of
38 E. Mau et al. / Developmental Biology 305 (2007) 28–39growth plate chondrocytes from their proliferative state into
terminal differentiation.
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